Dependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling schedule

Peptide Receptor ◽

Sampling Schedule

The role of patient-based treatment planning in peptide receptor radionuclide therapy

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-015-3248-6 ◽

2015 ◽

Vol 43 (5) ◽

pp. 871-880 ◽

Cited By ~ 19

Author(s):

Deni Hardiansyah ◽

Christian Maass ◽

Ali Asgar Attarwala ◽

Berthold Müller ◽

Peter Kletting ◽

...

Keyword(s):

Treatment Planning ◽

Radionuclide Therapy ◽

Treatment planning algorithm for peptide receptor radionuclide therapy considering multiple tumor lesions and organs at risk

Medical Physics ◽

10.1002/mp.13049 ◽

2018 ◽

Vol 45 (8) ◽

pp. 3516-3523 ◽

Cited By ~ 5

Author(s):

Luis David Jiménez-Franco ◽

Peter Kletting ◽

Ambros J. Beer ◽

Gerhard Glatting

Keyword(s):

At Risk ◽

Treatment Planning ◽

Radionuclide Therapy ◽

Organs At Risk ◽

Multiple Tumor ◽

Peptide Receptor ◽

Planning Algorithm

Sensitivity Analysis of a Physiologically Based Pharmacokinetic Model Used for Treatment Planning in Peptide Receptor Radionuclide Therapy

Cancer Biotherapy & Radiopharmaceuticals ◽

10.1089/cbr.2016.2012 ◽

2016 ◽

Vol 31 (6) ◽

pp. 217-224 ◽

Cited By ~ 4

Author(s):

Deni Hardiansyah ◽

Nusrat Jihan Begum ◽

Peter Kletting ◽

Felix M. Mottaghy ◽

Gerhard Glatting

Keyword(s):

Sensitivity Analysis ◽

Treatment Planning ◽

Radionuclide Therapy ◽

Pharmacokinetic Model ◽

Physiologically Based Pharmacokinetic Model ◽

Peptide Receptor ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based

Study of population and covariate model in physiologically based pharmacokinetics model used for treatment planning in peptide receptor radionuclide therapy

10.1063/5.0037544 ◽

2021 ◽

Author(s):

Ade Riana ◽

Supriyanto A. Pawiro ◽

Deni Hardiansyah

Keyword(s):

Treatment Planning ◽

Radionuclide Therapy ◽

Physiologically Based Pharmacokinetics ◽

Peptide Receptor ◽

Covariate Model ◽

Physiologically Based

Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy

Medical Physics ◽

10.1118/1.4752213 ◽

2012 ◽

Vol 39 (10) ◽

pp. 6118-6128 ◽

Cited By ~ 15

Author(s):

Sébastien Baechler ◽

Robert F. Hobbs ◽

Ariane Boubaker ◽

Franz Buchegger ◽

Bin He ◽

...

Keyword(s):

Treatment Planning ◽

Radionuclide Therapy ◽

Three Dimensional ◽

Nephrotoxicity and hematotoxicity one year after four cycles of peptide receptor radionuclide therapy (PRRT) and its impact on future treatment planning — A retrospective analysis

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) ◽

10.1016/j.remnie.2021.04.007 ◽

2021 ◽

Author(s):

Bernhard Nilica ◽

Anna Svirydenka ◽

Josef Fritz ◽

Steffen Bayerschmidt ◽

Alexander Kroiss ◽

...

Keyword(s):

Retrospective Analysis ◽

Treatment Planning ◽

Radionuclide Therapy ◽

Peptide Receptor ◽

Future Treatment ◽

One Year

Safety and efficacy of sequential local ablative therapy and peptide receptor radionuclide therapy in patients with neuroendocrine neoplasms and high tumor load; An analysis of 50 sequential patients

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-0035-1547651 ◽

2015 ◽

Vol 122 (03) ◽

Author(s):

D Hörsch

Keyword(s):

Radionuclide Therapy ◽

Neuroendocrine Neoplasms ◽

Safety And Efficacy ◽

Ablative Therapy ◽

Peptide Receptor ◽

Local Ablative Therapy ◽

Tumor Load

DNA damage response (DDR) and repair kinetics predict treatment response in patients receiving Lu-177-DOTA-TATE peptide receptor radionuclide therapy for advanced gastro-entero-pancreatic neuroendocrine tumors

10.1055/s-0040-1708134 ◽

2020 ◽

Author(s):

T Derlin ◽

N Bogdanova ◽

F Ohlendorf ◽

R Werner ◽

H Christiansen ◽

...

Keyword(s):

Dna Damage ◽

Treatment Response ◽

Neuroendocrine Tumors ◽

Dna Damage Response ◽

Radionuclide Therapy ◽

Pancreatic Neuroendocrine Tumors ◽

Peptide Receptor ◽

Damage Response ◽

Predict Treatment Response

Two Decades of THERANOSTICS in Neuroendocrine Tumors - Past, Presence and Future of Peptide Receptor Radionuclide Therapy (PRRT)

Endocrine Abstracts ◽

10.1530/endoabs.47.oc7 ◽

2016 ◽

Author(s):

Richard Baum

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Therapy ◽

Lanreotide depot/autogel before, during, and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumors (NETs): Data from the PRELUDE study

Endocrine Abstracts ◽

10.1530/endoabs.60.oc2 ◽

2018 ◽

Author(s):

Vikas Prasad ◽

Raj Srirajaskanthan ◽

Christos Toumpanakis ◽

Chiara Maria Grana ◽

Sergio Baldari ◽

...

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Therapy ◽